[Thromboembolic disease: prevention with low-molecular weight heparin in general surgery. Preliminary results].

Nine patients undergoing surgery lasting more than 45 minutes were included in the study. They received weekly anti-thromboembolic treatment with parnaparin (INN). Patients did not present thromboembolic complications following clinical and instrumental examination. Blood loss remained within the norm and no collateral effects were observed.